Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas B. Ottoboni | M | 65 | 12 years | |
| Craig Johnson | M | 62 | 10 years | |
| Sean T. Ristine | M | 54 | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Barry Quart | M | 67 | 11 years | |
| John W. Poyhonen | M | 64 | 9 years | |
| Gregory H. Turnbull | M | 85 | 26 years | |
| Robert H. Rosen | M | 68 | 7 years | |
| Elly Ryu | F | 43 | 10 years | |
| Kimberly Manhard | F | 64 | 9 years | |
| John B. Whelan | M | 62 | 4 years | |
| Stephen Davis | M | 63 | 3 years | |
| George Ng | M | 49 | 3 years | |
| Esmé c. Smith | F | 52 | - | |
| Brian Drazba | M | 63 | 4 years | |
| Jesse Hollingsworth | M | - | - | |
| Paul Goddard | M | 74 | 12 years | |
| Luigi Lenaz | M | 83 | 8 years | |
| James T. Glover | M | 74 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 3 years |
| James L. Freddo | M | 69 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 5 years |
| Lisa Peraza | F | 47 | 10 years | |
| Krishan K. Arora | M | 83 | 3 years | |
| Joel Schaedler | M | - | - | |
| Dilip J. Mehta | M | 91 | 2 years | |
| Casey Logan | M | 52 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 3 years |
| Paul Barone | M | - | - | |
| Amit Bhupendra Shah | M | 57 | 3 years | |
| Bimal Shah | M | 48 | 11 years | |
| Erin O’Boyle | F | - | 8 years | |
| John Barr | M | 64 | 15 years | |
| Nicholas A. Boyle | M | - | 2 years | |
| Paul G. Marshall | M | 64 | 3 years | |
| Abraham Noah Oler | M | 48 | 8 years | |
| James E. Shields | M | 72 | 2 years | |
| Andrew Sandler | M | 58 | 2 years | |
| Neil James Clendeninn | M | 74 | 1 years | |
| Thomas A. Pitler | M | 65 | - | |
| Larry C. Fritz | M | 71 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 1 years |
| Argeris Karabelas | M | 71 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | - |
| Mark Gelder | M | 67 | 3 years | |
| Amar P. Singh | M | 65 | 1 years | |
| Carol Gallagher | M | 59 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 1 years |
| Russell Skibsted | M | 65 | 3 years | |
| Christopher Nardo | M | 59 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 43 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael A. Adam
- Personal Network
